-
Trump Threatens Heavy Taxes on US Firms Building Data Centers Abroad
-
Kuwait DGCA Delegation Attends ICAO Assembly in Montreal
-
Gozo Minister Clint Camilleri Appointed CPMR Vice-President for Maritime Affairs
-
Charlie Puth and Ellie Goulding to Headline First Johnnie & Co. Festival in Mumbai
-
ALIX LASERS shareholders remove Michael Sobitsch as managing director in view of the circumstances
-
Maryland Woman Arrested in Decade-Long Cancer Scam Involving Fake Medical Team
-
Panthers Seek NFC South Lead Against Ravens as Baltimore Ends Skid
-
Closing a Business with Payroll Taxes Owed - Clear Start Tax Explains the Trust Fund Recovery Penalty
-
Ondas, Palantir and Regna AI Host Key Defense Technology Leaders to Accelerate the Path from AI Innovation to Fielded Capability
-
Dateline appoints Tony Ferguson as Acting Chairman
-
American Businessman Mark Eric Williams Vindicated in Six-Year, US$150 Million-Plus Litigation Brought by Kuwaiti State Entities
-
AI Search Engineers Says Longer AI Mode Questions Mean Professional Service Firms Should Answer Full Client Questions Directly on Their Pages
-
Arrive AI's Pro Forma Stockholders' Equity Now Above Nasdaq Minimum Requirement Following Recent Transactions
-
Who Does the Best Rhinoplasty in Sarasota?
-
PodcastOne (NASDAQ:PODC) Launches People Pleasers Podcast hosted by Comedians Leah Rudick and Jessica Michelle Singleton
-
Alset AI Closes Non-Brokered Private Placement Offering
-
Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
-
barq Signs MoU with TenPay Global to Enhance Remittances and Digital Payments in China
-
American Resources Corporation and ReElement Technologies Selected as Part of Winning U.S.-Led Consortium for Kenya's Strategic Mrima Hill Critical Minerals Project
-
Ryde Group Ltd Announces Non-Binding Term Sheet for Proposed Minority Investment in Multi Genius Limited and MOU on Technology Collaboration
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 20
-
Tosca's 2026 Sustainability Report Makes the Case for Packaging as Critical Supply Chain Infrastructure
-
The DEA Laid The Trap - And State Marijuana Operators Took The Bait
-
5 Fun Date Night Ideas That Don't Cost a Fortune
-
Cytta Air Expands Military Contracting Expertise - Appoints Rear Admiral James "Gib" Godwin III to Advisory Board
-
APEX FTE Expo 2026 Unites Aviation Leaders in Singapore and Honors Passenger Experience Excellence
-
APEX Honors Aeroméxico CEO Dr. Andrés Conesa with Historic APEX CEO Lifetime Achievement Award
-
Enmarket to Open Newest Eatery Location in Rincon, GA
-
Eylsia Nicolas Hits No. 1 on Groover's Global and US Singer-Songwriter Charts with "One More Moment," as Taglish Preview of "Wake Me Up for Christmas" Passes One Million Views in Under 24 Hours
-
What Is the Best Social Media Platform for Peptides?
-
WhalesBot Advances Creativity-Driven AI and Coding Education Through Pubbo AI
-
Karviva Introduces Unwined Alcohol-Free Malbec and Rose Varieties
-
Tidal Wave Auto Spa Opens New Locations in Murfreesboro, Tennessee and Asheville, North Carolina This Week
-
Peoples Bancorp Announces Cash Dividend
-
Jaguar Health, Inc. Announces Reverse Stock Split
-
Kartoon Studios' Beacon Media Partners With Bandai on Tamagotchi's Landmark 30th Anniversary Times Square Celebration
-
First Phosphate and Zeo Energy Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
enVVeno Medical Presents Three-Year Surgical Venous Valve Replacement Data Showing Sustained Clinical Benefit and Highlights Next-Generation enVVe Transcatheter System at the 53rd Annual VEITH Symposium
-
Taylor Bank Announces $125,000 Commitment to Diakonia's Supportive Living Campus Capital Campaign
-
AsiaFIN Holdings Corp. Appoints Fortune Angel INC as U.S. Reseller Partner to Expand Its Agentic and Robotic Process Automation SaaS Business Across New York and the East Coast
-
Commonhold Explained: How New Leasehold Ban Changes Property Ownership in England and Wales
-
Factory Worker Dies in Rare Rectal Explosion Incident in Czechia
-
GIRLBAND! Headline Show at Rough Trade Marks National Breakthrough
Institutional Capital Confirms Marijuana Future: MMJ International Holdings FDA Regulated Plant Based Medicine
WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / In a rapidly evolving cannabis biopharmaceutical landscape, MMJ International Holdings stands as a pioneer that has spent nearly a decade advancing an FDA regulated, pharmaceutical grade pathway for cannabinoid based therapeutics.

Duane Boise, President & CEO of MMJ International Holdings
A Pharmaceutical Approach in a Fast-Maturing Market
The momentum toward scientifically validated plant medicines continues to accelerate.
Recent institutional financings - such as Cybin Inc.'s $175 million raise backed by OrbiMed, Venrock, Point72, and Deep Track Capital - demonstrate Wall Street's growing appetite for regulated botanical therapeutics.
MMJ's vertically integrated model - MMJ BioPharma Cultivation , MMJ BioPharma Labs , and MMJ International Holdings - ensures control from seed to softgel, guaranteeing pharmaceutical-grade quality, purity, and reproducibility.
MMJ's Regulatory Milestones
Drug Candidate | Indication | Key Regulatory Milestones | Status |
|---|---|---|---|
MMJ-002 | Huntington's Disease (HD) | • FDA Orphan Drug Designation • IND application accepted | Phase II trials pending |
MMJ-001 | Multiple Sclerosis (MS) | • IND application filed | Phase II trials pending |
Distinct Advantages:
Natural vs. Synthetic: MMJ's THC/CBD softgels harness the entourage effect, unlike synthetic isolates such as Marinol.
Standardization & Precision: Every capsule meets Good Manufacturing Practice (GMP) standards for reproducible dosing and purity.
Vertical Integration: MMJ controls cultivation, extraction, and formulation to maintain full traceability and pharmaceutical consistency.
DEA Regulatory Bottlenecks - and a Turning Point in Washington
For years, MMJ BioPharma Cultivation has faced a seven-year delay in obtaining DEA bulk-manufacturing registration, trapped in a legal paradox that required a "bona fide supply agreement" before a license could be issued - an impossible demand under federal law.
This bureaucratic Catch-22 has obstructed FDA-approved science, delayed critical treatments, and cost American patients years of progress.
But change is underway.
Amid the recent federal government shutdown and restructuring, several thousand entrenched bureaucrats - including within the DEA's Diversion Division - have been dismissed, clearing the pathway for accountability and reform across federal agencies.
These reforms create an unprecedented opportunity for agencies like the DEA to modernize their processes, remove conflicts of interest, and finally enable companies like MMJ International Holdings to fulfill the scientific mandate Congress envisioned when it authorized Schedule I research decades ago.
"With Washington finally cleaning house, we now have a real opportunity to restore science-based policy," Boise said. "Thousands of redundant bureaucratic positions have been eliminated, including within the DEA Diversion Division - creating a pathway for lawful, transparent reform. Patients have waited long enough."
Patient and Economic Impact
For patients suffering from Huntington's disease and multiple sclerosis, each delay means continued dependence on ineffective therapies.
Analysts project the global cannabinoid-pharmaceutical market will exceed $50 billion by 2030, but unless reforms translate into timely DEA licensing, the U.S. risks forfeiting that leadership to European and Asian manufacturers.
The success of GW Pharmaceuticals' Epidiolex®, a plant-derived CBD drug that achieved nearly $1 billion in annual sales, proves that the market rewards compliant science.
MMJ International Holdings aims to replicate this success through its FDA-accepted INDs, Orphan Drug Designations, and GMP infrastructure ready for immediate scale-up once the DEA fulfills its statutory duties.
Call to Action: President Trump & DEA Administrator Terry Cole
MMJ International Holdings calls on President Donald J. Trump and DEA Administrator Terry Cole to ensure the agency completes this reform by:
Issuing DEA bulk-manufacturing registrations before supply-agreement requirements;
Eliminating outdated bureaucratic barriers that contradict FDA research protocols; and
Restoring patient access and U.S. competitiveness through a unified, lawful framework.
"The science is ready, the patients are waiting, and the bureaucracy is finally being cleared out," Boise emphasized. "Now it's time for leadership."
About MMJ International Holdings
MMJ International Holdings Inc. is a U.S.-based biopharmaceutical company dedicated to developing FDA-approved, cannabinoid-derived medicines for rare and chronic diseases. Its subsidiaries - MMJ BioPharma Cultivation and MMJ BioPharma Labs - operate within DEA and FDA frameworks to produce standardized, pharmaceutical-grade formulations for neurological and chronic conditions.
MMJ is represented by attorney Megan Sheehan
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
J.Gomez--AT